Simvastatin Treatment Modulates Mechanically-Induced Injury and Inflammation in Respiratory Epithelial Cells

Area of Science:

• Cell Biology
• Respiratory Medicine
• Pharmacology

Background:

• Mechanical forces in the respiratory system can cause epithelial cell injury, barrier disruption, and inflammation.
• Understanding cellular responses to mechanical stress is crucial for treating respiratory conditions.

Purpose of the Study:

• To investigate Simvastatin's potential to mitigate mechanically induced injury and inflammation in respiratory epithelial cells.
• To determine the effects of Simvastatin on cell mechanics and inflammatory responses under mechanical stress.

Main Methods:

• Pulmonary alveolar epithelial cells (A549) were subjected to cyclic airway reopening forces or oscillatory transmural pressure in vitro.
• Cells were treated with various concentrations of Simvastatin.
• Cell morphology, elastic modulus, viscoelastic properties, and pro-inflammatory cytokine secretion (IL-6, IL-8) were assessed.

Main Results:

• Simvastatin caused reversible actin cytoskeleton depolymerization and reduced the cell's elastic modulus.
• Simvastatin treatment led to a decreased height-to-width aspect ratio, significantly reducing cell injury during airway reopening.
• High Simvastatin concentrations (25-50 µM) reduced pro-inflammatory cytokine secretion, but lower concentrations (2.5 µM) did not.

Conclusions:

• Simvastatin can reduce mechanical injury in respiratory epithelial cells, particularly during airway reopening, by altering cell morphology.
• Significant reduction in mechanically induced inflammation requires high Simvastatin concentrations, indicating potential need for localized delivery strategies.